Precision screening · Genetics
TP53 testing:
read your genome’s guardian.
The TP53 gene is the cell’s master anti-cancer defence. A germline TP53 test reveals whether your inherited copy carries a known weakness — turning a vague family worry into a concrete, counselled surveillance plan. Delivered with genetic counselling at China’s Class A hospitals from $250.
p53
Guardian of the genome
Central anti-cancer defence protein
Molecular biology
Germline
Inherited copy tested
Not the somatic tumour mutation
Test scope
LFS
Li-Fraumeni syndrome
Rare, high-penetrance variant
Clinical genetics
$250–900
All-in cost
Single gene or panel + counselling
Partner quotes 2026
Counselled
Always
Pre- and post-test genetic counselling
Editorial standard
Class A
All partner centres
Medical-genetics departments
NHC
What it is
The body’s brake
on cancer.
Every time a cell’s DNA is damaged, a protein called p53 decides what happens next — pause and repair, or self-destruct before the damage becomes cancer. The gene that builds it, TP53, is one of the most important tumour suppressors in human biology, which is why it is nicknamed the guardian of the genome.
A germline TP53 test reads the copy of this gene you inherited and carry in every cell. A pathogenic variant — the condition known as Li-Fraumeni syndrome — substantially raises lifetime cancer risk and pushes cancers to earlier ages. It is rare, so for most people the result is normal and reassuring.
Where it matters, it matters a great deal: a confirmed carrier gains an intensive early-detection plan that genuinely changes outcomes. That is why we treat TP53 as targeted, counselled testing — best for those with relevant family history, and always returned with genetic counselling. It sits alongside multi-cancer early detection in the precision-screening layer of longevity medicine.
What p53 does
Why this one gene matters.
DNA-damage sensor
When DNA is damaged, p53 pauses the cell cycle so repair machinery can act before the cell divides and propagates the error.
Repair or self-destruct
If damage is beyond repair, p53 triggers apoptosis — programmed cell death — removing the cell before it can turn malignant.
Tumour suppression
By gatekeeping division and clearing damaged cells, p53 is one of the body’s most important brakes on cancer formation.
The inherited baseline
Your germline TP53 copy sets your innate anti-cancer defence. Testing reveals whether that baseline carries a known weakness worth surveilling.
How we position it
Four things we tell every patient.
Most results are normal
Pathogenic germline TP53 variants are rare. For most people a normal result is the expected, reassuring outcome — and that itself is useful information.
Family history drives value
The test is most informative when there is early-onset or multiple-primary cancer history. We assess that first rather than testing reflexively.
A variant is actionable
Carriers gain a concrete intensive-surveillance plan (whole-body/breast MRI, ultrasound) that catches cancers early — risk information, not a verdict.
Never a raw lab value
Results, including variants of uncertain significance, are returned with genetic counselling so they are interpreted correctly and not over- or under-read.
TP53 testing is most appropriate for individuals with relevant personal or family cancer history. For the general population a single-gene test in isolation has limited value, and we will recommend guideline-based screening or a broader counselled panel instead where that fits better. All results are returned with genetic counselling.
The pathway
From family history
to a clear plan.
History & counselling
A medical geneticist reviews your personal and family cancer history and explains what the test can and cannot tell you, so you can give informed consent.
Sample collection
A simple blood or saliva sample is collected at a Class A hospital, often combined with a longevity phenotyping visit or executive physical.
Sequencing & analysis
The laboratory sequences your germline TP53 (or a broader hereditary-cancer panel) and classifies any variants found against curated databases. Turnaround ~2–4 weeks.
Counselled report
Results are returned in a post-test counselling session with a bilingual report — explaining the finding, its implications for you and relatives, and next steps.
Surveillance plan
For confirmed carriers we help establish an appropriate surveillance protocol (e.g. periodic whole-body and breast MRI) at the same Class A hospital, with bilingual records.
FAQ
TP53 testing, answered.
- What is the TP53 gene?
- TP53 is the gene that encodes the p53 protein, often called the ‘guardian of the genome.’ When a cell’s DNA is damaged, p53 halts the cell cycle to allow repair, and — if the damage is too great — triggers the cell to self-destruct rather than become cancerous. It is one of the body’s central anti-cancer defences. Acquired (somatic) TP53 mutations are among the most common findings across human cancers, but a TP53 genetic test in this context looks specifically at your inherited (germline) copy — the baseline anti-cancer defence you were born with.
- What does a germline TP53 variant mean?
- Inheriting a pathogenic germline TP53 variant means one of your two TP53 copies is impaired in every cell — a condition called Li-Fraumeni syndrome (LFS). It is rare but carries a substantially elevated lifetime cancer risk and a tendency toward earlier-onset and multiple primary cancers, including sarcomas, early breast cancer, brain tumours, adrenocortical carcinoma and leukaemia. Importantly, most people who feel concerned about cancer do not carry such a variant — LFS is uncommon, and a normal TP53 result is the expected outcome for the general population.
- Who should actually be tested for TP53?
- Testing is most meaningful for people with features suggesting hereditary risk: a strong personal or family history of early-onset cancers, multiple primary cancers in one person, specific tumour types associated with LFS (such as childhood adrenocortical carcinoma or choroid plexus tumours), or a known TP53 variant in the family. For a healthy adult with no such history, the prior probability of carrying a pathogenic TP53 variant is very low, and a single-gene TP53 test in isolation is often less useful than guideline-based screening or a broader counselled hereditary-cancer panel. We assess your family history before recommending it.
- What happens if I carry a pathogenic variant?
- A positive result is not a cancer diagnosis — it is risk information that enables action. For confirmed LFS, international guidelines recommend an intensive surveillance protocol (often the ‘Toronto protocol’): regular whole-body and brain MRI, breast MRI for women, abdominal ultrasound and clinical review, designed to catch cancers early when they are most treatable. It also informs decisions about avoiding unnecessary radiation, and gives relatives the option of cascade testing. This is precisely why TP53 results must be returned with genetic counselling, never as a raw lab value.
- Why is genetic counselling essential here?
- A TP53 result carries weight far beyond a single number. A pathogenic variant has lifelong implications for you and blood relatives, affects insurance and family-planning decisions in some jurisdictions, and demands a structured surveillance plan. Variants of uncertain significance (VUS) are also common and must not be over-interpreted. For all these reasons our partners return TP53 testing with pre-test and post-test genetic counselling, so the result is understood in context and translated into a concrete, appropriate plan — or appropriate reassurance.
- How much does TP53 testing cost in China?
- All-in international-patient pricing for germline TP53 testing runs roughly $250–$900 depending on whether it is ordered as a single gene or within a broader hereditary-cancer panel, plus genetic counselling. A targeted single-variant test (for a known familial mutation) sits at the lower end; comprehensive multi-gene panels that include TP53 alongside BRCA1/2 and other predisposition genes sit higher. Pricing includes sample collection, sequencing, interpretation and a bilingual counselled report.
- Can foreigners get TP53 testing in China?
- Yes. International patients access germline TP53 and broader hereditary-cancer testing through the medical-genetics and oncology departments of Class A hospitals, with bilingual genetic counselling. Panda Touring Care arranges the consultation, sample collection (a blood or saliva sample, often combined with a longevity visit), laboratory analysis and a counselled bilingual report — and, for confirmed carriers, helps set up an appropriate surveillance pathway.
Continue exploring
Multi-Cancer Early Detection
Pan-cancer methylation blood testing — a wider net across many cancers.
Read on MCEDCellular Function Testing
A 113-marker scan of metabolic and cellular function behind fatigue and decline.
Read on cell functionGenetic Screening
Broader hereditary and carrier screening as a healthspan add-on.
Read on screeningBreast Cancer in China
Where TP53-informed surveillance connects to breast oncology.
See breast cancerCancer Treatment in China
The full oncology pathway at Class A hospitals.
See oncologyLongevity Medicine Hub
The full screening-and-intervention overview.
Back to hubShould you test
your TP53 baseline?
Tell us your personal and family cancer history. A medical geneticist will tell you honestly whether germline TP53 testing — or a broader counselled panel — is right for you, and what a result would actually mean.